Chapter 32 Genotype-phenotype correlations in hereditary muscle diseases. Implications for diagnosis and treatment

Supplements to Clinical Neurophysiology

Volumn 57, Issue C, 2004, Pages 322-333

  Leshner, Robert T ^a  

^a Physical Medicine and Rehabilitation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FKRP PROTEIN, HUMAN; LAMININ; PROTEIN;

DIFFERENTIAL DIAGNOSIS; GENETIC DISORDER; GENETICS; GENOTYPE; HUMAN; LIMB GIRDLE MUSCULAR DYSTROPHY; METABOLISM; MUSCLE DISEASE; MYOTONIC DYSTROPHY; PHENOTYPE; REVIEW;

DIAGNOSIS, DIFFERENTIAL; GENETIC DISEASES, INBORN; GENOTYPE; HUMANS; LAMININ; MUSCULAR DISEASES; MUSCULAR DYSTROPHIES, LIMB-GIRDLE; MYOTONIC DYSTROPHY; PHENOTYPE; PROTEINS;

EID: 25144497468     PISSN: 1567424X     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1567-424X(09)70368-X     Document Type: Article

References (36)

1. Anderson L.V.B., Bushby K.M.D., Hanna M.G., Muntoni F.N., Hilton-Jones D., and Newsom-Davis J. Diagnosing rare neuromuscular diseases-the jump from research to service. J. Neurol. Sci. 199 Suppl. (2002) S72
2. Barkovich A.J., Kuzniecky R.I., Jackson G.D., Guerrini R., and Dobyns W.B. Classification system for malformations of cortical development: update 2001. Neurology 57 12 (2002) 2168-2178
3. Beggs A.H. Dystrophinopathy, the expanding phenotype. Dystrophin abnormalities in X-linked dilated cardiomyopathy (editorial; comment). Circulation 95 (1997) 2344-2347
4. Beltran-Valero DeBernabe D., Currier S., Steinbrecher A., Celli J., Van Beusekom E., Van der Zwaag B., Kayserili H., Merlini L., Chitayat D., Dobyns W.B., Cormand B., Lehesjoki A.E., Cruces J., Voit T., Walsh C.A., Van Bokhoven H., and Brunner H.G. Mutations in the O-mannosyltransferase gene POMT1 give rise to the severe neuronal migration disorder Walker-Warburg syndrome. Am. J. Hum. Genet. 71 (2002) 1033-1043
5. Bonne G., Yaou R.B., Beroud C., Boriani G., Brown S., DeVisser M., Duboc D., Ellis J., Hausmanowa-Petrusewicz I., Lattanzi G., Merlini L., Morris G., Muntoni F., Opolski G., Pinto Y.M., Sangiuolo F., Toniolo D., Trembath R., Van Berlo J.H., and Van der Kooi A.J. 7th International Emery-Dreifuss Muscular Dystrophy (EDMD) Workshop, 13-15 September, 2002, Naarden, The Netherlands. Neuromuscul. Disord. 13 6 (2003) 508-515
6. Brockington M., Blake D.J., Prandini P., Brown S.C., Torelli S., Benson M.A., Ponting C.P., Estournet B., Romero N.B., Mercuri E., Voit T., Sewry C.A., Guicheney P., and Muntoni F. Mutations in the fukutin-related protein gene(FKRP) cause a form of congenital muscular dystrophy with secondary laminin alpha2 deficiency and abnormal glycosylation of alpha-dystroglycan. Am. J. Hum. Genet. 69 (2001) 1198-1209
7. Bushby K.M. Making sense of the limb-girdle muscular dystrophies. Brain 122 (1999) 1403-1420 Pt. 8
8. Bushby K.M., and Beckmann J.S. The 105th ENMC sponsored workshop: pathogenesis in the non-sarcoglyclan limb-girdle muscular dystrophies. Neuromusc. Disord. 13 (2003) 80-90
9. Cormand B., Pihko H., Bayes M., Valanne L., Santavuori P., Talim B., Gershoni-Baruch R., Ahmad A., Van Bokhoven H., Brunner H.G., Voit T., Topaloglu H., Dobyns W.B., and Lehesjoki A.E. Clinical and genetic distinction between Walker-Warburg syndrome and muscle-eye-brain disease. Neurology 56 (2001) 1059-1069
10. Den Dunnen J.T., Grootscholten P.M., Bakker E., Blonden L.A., Ginjaar H.B., Wapenaar M.C., Van Paassen H.M., Van Broeckhoven C., Pearson P.L., and Van Ommen G.J. Topography of the Duchenne muscular dystrophy (DMD) gene: FIGE and cDNA analysis of 194 cases reveals 115 deletions and 13 duplications. Am. J. Hum. Genet. 45 (1989) 835-847
11. Martinelli Felisari G., Boneschi F., Bardoni A., Sironi M., Comi G.P., Robotti M., Turconi A.C., Lai M., Corrao G., and Bresolin N. Loss of Dp 140 dystrophin isoform and intellectual impairment in Duchenne dystrophy. Neurology 55 (2000) 559-564
12. Fenichel G.M., Florence J.M., Pestronk A., Mendell J.R., Moxley III R.T., Griggs R.C., Brooke M.H., Miller J.P., Robison J., King W., et al. Long-term benefit from prednisone therapy in Duchenne muscular dystrophy. Neurology 41 (1991) 1874-1877
13. Gabellini D., Green M.R., and Tupler R. Inappropriate gene activation in FSHD: a repressor complex binds a chromosomal repeat deleted in dystrophic muscle. Cell 110 (2002) 339-348
14. Gordon, E., Hoffman, E.P. and Pegoraro, E. Congenital muscular dystrophy overview www.genetests.org.
15. Griggs R.C., Moxley III R.T., Mendell J.R., Fenichel G.M., Brooke M.H., Pestronk A., and Miller J.P. Prednisone in Duchenne dystrophy. A randomized, controlled trial defining the time course and dose response. Clinical Investigation of Duchenne Dystrophy Group. Arch. Neurol. 48 (1991) 383-388
16. Haltia M., Leivo I., Somer H., Pihko H., Paetau A., Kivela T., Tarkkanen A., Tome F., Engvall E., and Santavuori P. Muscle-eye-brain disease: a neuropathological study. Ann. Neurol. 41 (1997) 173-180
17. Hayashi Y.K., Ogawa M., Tagawa K., Noguchi S., Ishihara T., Nonaka I., and Arahata K. Selective deficiency of alpha-dystroglycan in Fukuyama-type congenital muscular dystrophy. Neurology 57 (2001) 115-121
18. Hoffman E.P., Brown Jr. R.H., and Kunkel L.M. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 51 (1987) 919-921
19. Hoffman E.P., Arahata K., Minetti C., Bonilla E., and Rowland L.P. Dystrophinopathy in isolated cases of myopathy in females. Neurology 42 (1992) 967-975
20. Kobayashi D., Nakahori Y., Miyake M., Matsumura K., Toda T., et al. An ancient transposal insertion causes Fukuyama-type congenital muscular dystrophy. Nature 394 6691 (1998) 388-392
21. Koenig M., Beggs A.H., Moyer M., Scherpf S., Heindrich K., Bettecken T., Meng G., Muller C.R., Lindlof M., Kaariainen H., et al. The molecular basis for Duchenne vs. Becker muscular dystrophy: correlation of severity with type of deletion. Am. J. Hum. Genet. 45 (1989) 498-506
22. Mendell J.R., Buzin C.H., Feng J., Yan J., Serrano C., Sangani D.S., Wall C., Prior T.W., and Sommer S.S. Diagnosis of Duchenne dystrophy by enhanced detection of small mutations. Neurology 57 (2001) 645-650
23. Mercuri E., Yuva Y., Brown S.C., Brockington M., Kinali M., Jungbluth H., Feng L., Sewry C.A., and Muntoni F. Collagen VI involvement in Ullrich syndrome: a clinical, genetic, and immunohistochemical study. Neurology 58 (2002) 1354-1359
24. Mercuri E., Brockington M., Straub V., Quijano-Roy S., Yuva Y., Herrmann R., Brown S.C., Torelli S., Dubowitz V., Blake D.J., Romero N.B., Estournet B., Sewry C.A., Guicheney P., Voit T., and Muntoni F. Phenotypic spectrum associated with mutations in the fukutin-related protein gene. Ann. Neurol. 53 4 (2003) 537-542
25. Monaco A.P., Neve R.L., Colletti-Feener C., Bertelson C.J., Kurnit D.M., and Kunkel L.M. Isolation of candidate cDNAs for portions of the Duchenne muscular dystrophy gene. Nature 323 (1986) 646-650
26. Monaco A.P., Bertelson C.J., Liechti-Gallati S., Moser H., and Kunkel L.M. An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus. Genomics 2 (1988) 90-95
27. Nonaka I. Distal myopathies. Curr. Opin. Neurol. 12 (1999) 493-499
28. Pegoraro E., Mancias P., Swerdlow S.H., Raikow R.B., Garcia C., Marks H., Crawford T., Carver V., Di Cianno B., and Hoffman E.P. Congenital muscular dystrophy with primary laminin alpha2 (merosin) deficiency presenting as inflammatory myopathy. Ann. Neurol. 40 (1996) 782-791
29. Philpot J., Cowan F., Pennock J., Sewry C., Dubowitz V., Bydder G., and Muntoni F. Merosin-deficient congenital muscular dystrophy: the spectrum of brain involvement on magnetic resonance imaging. Neuromuscul. Disord. 9 (1999) 81-85
30. Tawil R., Forrester J., Griggs R.C., Mendell J., Kissel J., McDermott M., King W., Weiffenbach B., and Figlewicz D. Evidence for anticipation and association of deletion size with severity in facioscapulohumeral muscular dystrophy. The FSH-DY Group. Ann. Neurol. 39 (1996) 744-748
31. Tezak Z., Prandini P., Boscaro M., Marin A., Devaney J., Marino M., Fanin M., Trevisan C.P., Park J., Tyson W., Finkel R., Garcia C., Angelini C., Hoffman E.P., and Pegoraro E. Clinical and molecular study in congenital muscular dystrophy with partial laminin alpha 2 (LAMA2) deficiency. Hum. Mutat. 21 (2003) 103-111
32. Toda T., Kobayashi K., Kondo-Iida E., Sasaki J., and Naka-mura Y. The Fukuyama congenital muscular dystrophy story. Neuromuscul. Disord. 10 (2000) 153-159
33. Towbin J.A., Hejtmancik J.F., Brink P., Gelb B., Zhu X.M., Chamberlain J.S., McCabe E.R., and Swift M. X-linked dilated cardiomyopathy. Molecular genetic evidence of linkage to the Duchenne muscular dystrophy (dystrophin) gene at the Xp21 locus. Circulation 87 (1993) 1854-1865
34. Upadhyaya M., and Cooper D.N. Molecular diagnosis of facioscapulohumeral muscular dystrophy. Expert Rev. Mol. Diagn. 2 (2002) 160-171
35. Vainzof M., Passos-Bueno M.R., Pavanello R.C., Marie S.K., Oliveira A.S., and Zatz M. Sarcoglycanopathies are responsible for 68% of severe autosomal recessive limb-girdle muscular dystrophy in the Brazilian population. J. Neurol. Sci. 164 (1999) 44-49
36. Van Deutekom J.C., Wijmenga C., Van Tienhoven E.A., Gruter A.M., Hewitt J.E., Padberg G.W., Van Ommen G.J., Hofker M.H., and Frants R.R. FSHD associated DNA rearrangements are due to deletions of integral copies of a 3.2 kb tandemly repeated unit. Hum. Mol. Genet. 2 (1993) 2037-2042